SEC Form 4 · accession 0000805928-26-000076
Axogen, Inc. · AXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William P. Mr. Burke
Director
Period of report
Jun 19, 2026
Accepted (ET)
Jun 23, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000805928
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 19, 2026 | M | 14,150 | $0.00 | A | 14,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Jun 19, 2026 | M | 14,150 | A | — | — | Common Stock | 14,150 | 0 | D |
Explanation of responses
- F1This reflects the number of restricted stock units that vested June 19, 2026.
- F2Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- F3Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.